Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jorge Velarde and John Rueter

Premium

BaseHealth has tapped Jorge Velarde to serve as its CEO and president. He is taking over from Hossein Fakhrai-Rad, current chairman of the board, who is now transitioning into a new role as the company's chief scientific officer.

Before taking on the role of CEO, Velarde was the interim CEO and senior vice president of business development and marketing at BaseHealth. Before he joined the company, Velarde was vice president of business development at Illumina. He also worked in business development at Gen-Probe, which was acquired by Hologic in 2012.


Cambridge Semantics has hired John Rueter as its new vice president of marketing. In the role, he'll oversee activities related to the company's corporate and product marketing, as well as demand generation and product management.

Previously, Rueter served as vice president of marketing for Endeca, a provider of big data management solutions. Before that, he served as chief marketing officer of StreamServe and as senior vice president of global marketing for Fast Search & Transfer. Rueter has an MBA with a concentration in marketing and management policy from Boston University Graduate School of Management, and a bachelor’s degree from Harvard College.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.